EP0832653 - Use of cytokines and cytotoxic compounds in a method for treatment of tumours [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.07.1999 Database last updated on 24.08.2024 | Most recent event Tooltip | 27.08.1999 | Change - German title | published on 13.10.1999 [1999/41] | Applicant(s) | For all designated states MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN Robert-Rössle-Strasse 10 13125 Berlin / DE | [N/P] |
Former [1998/14] | For all designated states MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN Robert-Rössle-Str. 10 D-13125 Berlin / DE | Inventor(s) | 01 /
Stein, Ulrike, Dr. Theodor-Brugsch-Str. 36 13125 Berlin / DE | 02 /
Walther, Wolgang, Dr. Theodor-Brugsch-Str. 36 13125 Berlin / DE | 03 /
Schlag, Peter M., Prof. Dr. Frohnauer Str. 17a 13467 Berlin / DE | [1998/14] | Representative(s) | Baumbach, Friedrich Patentanwalt Robert-Rössle-Strasse 10 13125 Berlin / DE | [N/P] |
Former [1998/14] | Baumbach, Friedrich BioTeZ Berlin-Buch GmbH Patentstelle Robert-Rössle-Strasse 10 13125 Berlin / DE | Application number, filing date | 96250206.8 | 20.09.1996 | [1998/14] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | EP0832653 | Date: | 01.04.1998 | Language: | DE | [1998/14] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.04.1997 | Classification | IPC: | A61K38/20, A61K38/19, // A61K31/00 | [1998/14] | CPC: |
A61K38/191 (EP,US);
A61K38/2013 (EP,US);
A61P35/00 (EP)
| Designated contracting states | (deleted) [1998/51] |
Former [1998/14] | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE | Title | German: | Verwendung von Cytokinen und cytotoxischen Substanzen in einem neuen Verfahren zur Tumorbehandlung | [1999/41] | English: | Use of cytokines and cytotoxic compounds in a method for treatment of tumours | [1998/14] | French: | Utilisation de cytokines en de composés cytotoxiques dans une méthode de traitement des tumeurs | [1998/14] |
Former [1998/14] | Verwenddung von Cytokinen und cytotoxischen Substanzen in einem neuen Verfahren zur Tumorbehandlung | Examination procedure | 02.10.1998 | Application deemed to be withdrawn, date of legal effect [1999/37] | 22.02.1999 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [1999/37] | Fees paid | Penalty fee | Penalty fee Rule 85a EPC 1973 | 03.12.1998 | AT   M01   Not yet paid | 03.12.1998 | BE   M01   Not yet paid | 03.12.1998 | CH   M01   Not yet paid | 03.12.1998 | DE   M01   Not yet paid | 03.12.1998 | DK   M01   Not yet paid | 03.12.1998 | ES   M01   Not yet paid | 03.12.1998 | FI   M01   Not yet paid | 03.12.1998 | FR   M01   Not yet paid | 03.12.1998 | GB   M01   Not yet paid | 03.12.1998 | GR   M01   Not yet paid | 03.12.1998 | IE   M01   Not yet paid | 03.12.1998 | IT   M01   Not yet paid | 03.12.1998 | LU   M01   Not yet paid | 03.12.1998 | NL   M01   Not yet paid | 03.12.1998 | PT   M01   Not yet paid | 03.12.1998 | SE   M01   Not yet paid | Penalty fee Rule 85b EPC 1973 | 03.12.1998 | M01   Not yet paid | Additional fee for renewal fee | 30.09.1998 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9601121 (GENENTECH INC [US]) [X] 1-10 * the whole document *; | [X] - HO R. ET AL., "Development of Safe and Effective Adriamycin Plus Inteleukin 2 Therapy Against Both Adriamycin-Sensitive and -Resistant Lymphomas", ONCOLOGY RESEARCH, (1993), vol. 5, no. 9, pages 373 - 381, XP000645160 [X] 1-10 * the whole document * | [X] - NABIOULLIN R ET AL, "Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.", JAPANESE JOURNAL OF CLINICAL ONCOLOGY 25 (4). 1995. 124-130, XP000645157 [X] 1-10 * the whole document * | [X] - REGENASS U. ET AL., "TNF in combination with cytostatic agents", EXPERIENTIA, (1986), vol. 42, no. 6, page 701, XP002026299 [X] 1-10 * the whole document * | [DX] - WALTHER W ET AL, "Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: Increased cytotoxicity of MDR relevant drugs.", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 120 (8). 1994. 471-478, XP000645076 [DX] 1-10 * the whole document * DOI: http://dx.doi.org/10.1007/BF01191800 | [DX] - WALTHER W ET AL, "Gene transfer of human TNF-alpha into glioblastoma cells permits modulation of mdr1 expression and potentiation of chemosensitivity.", INTERNATIONAL JOURNAL OF CANCER 61 (6). 1995. 832-839, XP000645062 [DX] 1-10 * the whole document * DOI: http://dx.doi.org/10.1002/ijc.2910610615 |